European Commission
Public Health
Accessibility tools
Go to content
Service tools
Legal notice
Contact
Search
Language selector
Current language
en
Navigation path
European Commission
Public health
Reference documents
Register
Human
Print version
Decrease text
Increase text
share on Facebook
share on Twitter
share on Stumbleupon
share on linkedin
Community Register of medicinal products
Community register of medicinal products for human use
Alphabetical
EU/1/12/768/ - Riluzole Zentiva (Aventis Pharma S.A.)
EU/1/12/767/ - Nimenrix (GlaxoSmithKline Biologicals S.A.)
EU/1/12/766/ - SANCUSO (ProStrakan Limited)
EU/1/12/765/ - Sabervel (Pharmathen S.A.)
EU/1/12/764/ - Pixuvri (CTI Life Sciences Ltd)
EU/1/12/763/ - Capecitabine Krka (KRKA, d.d)
EU/1/12/762/ - Capecitabine Accord (Accord Healthcare Limited)
EU/1/12/761/ - Capecitabine Teva (TEVA Pharma B.V.)
EU/1/12/760/ - Bronchitol (Pharmaxis Pharmaceuticals Limited)
EU/1/12/759/ - Zoledronic acid Actavis (Actavis Group PTC ehf.)
EU/1/12/758/ - Pioglitazone Teva Pharma (Teva Pharma B.V.)
EU/1/12/757/ - Pioglitazone Teva (Teva Pharma B.V.)
EU/1/12/756/ - Glidipion (Actavis Group PTC ehf.)
EU/1/12/755/ - Pioglitazone Actavis (Actavis Group PTC ehf. )
EU/1/12/754/ - Sepioglin (Vaia S.A.)
EU/1/12/753/ - Signifor (Novartis Europharm Limited)
EU/1/12/752/ - Vepacel (Baxter Innovations GmbH)
EU/1/12/751/ - Zelboraf (Roche Registration Limited)
EU/1/12/750/ - Esmya (PregLem France SAS.)
EU/1/11/749/ - Caprelsa (AstraZeneca AB)
EU/1/11/748/ - Docetaxel Mylan (Mylan S.A.S)
EU/1/11/747/ - Colobreathe (Forest Laboratories UK Ltd)
EU/1/11/746/ - Desloratadine ratiopharm (ratiopharm GmbH)
EU/1/11/745/ - Desloratadine Actavis (Actavis Group PTC ehf.)
EU/1/11/744/ - Topotecan Eagle (Eagle Laboratories Limited)
EU/1/11/743/ - Repaglinide Accord (Accord Healthcare Limited)
EU/1/11/742/ - Efavirenz Teva (Teva Pharma BV)
EU/1/11/741/ - Levetiracetam SUN (Sun Pharmaceutical Industries Europe BV)
EU/1/11/740/ - Ameluz (Biofrontera Bioscience GmbH)
EU/1/11/739/ - Dasselta (KRKA, d.d., Novo mesto)
EU/1/11/738/ - Levetiracetam Actavis Group (Actavis Group PTC ehf.)
EU/1/11/737/ - Eviplera (Gilead Sciences International Limited)
EU/1/11/736/ - EDURANT (Janssen-Cilag International NV)
EU/1/11/735/ - Ipreziv (Takeda Global Research and Development Centre (Europe) Ltd)
EU/1/11/734/ - Edarbi (Takeda Global Research and Development Centre (Europe) Ltd)
EU/1/11/733/ - Dificlir (Astellas Pharma Europe B.V.)
EU/1/11/732/ - Desloratadine Teva (Teva Pharma B.V.)
EU/1/11/731/ - Komboglyze (Bristol Myers Squibb/AstraZeneca EEIG)
EU/1/11/730/ - Rasitrio (Novartis Europharm Limited)
EU/1/11/729/ - Onduarp (Boehringer Ingelheim International GmbH)
EU/1/11/728/ - Pramipexole Accord (Accord Healthcare Limited)
EU/1/11/727/ - Mercaptopurine Nova Laboratories (Nova Laboratories Limited)
EU/1/11/723/ - Pioglitazone Krka (KRKA, d. d., Novo mesto)
EU/1/11/722/ - Pioglitazone Accord (Accord Healthcare Limited)
EU/1/11/721/ - Paglitaz (KRKA, d. d., Novo mesto)
EU/1/11/720/ - Incivo (Janssen-Cilag International NV)
EU/1/11/719/ - Telmisartan Teva Pharma (Teva Pharma B.V.)
EU/1/11/718/ - Dexdor (Orion Corporation)
EU/1/11/717/ - Vyndaqel (Pfizer Specialty UK Limited )
EU/1/11/716/ - Eurartesim (Sigma-Tau Industrie Farmaceutiche Riunite S.p.A)
EU/1/11/715/ - Plenadren (ViroPharma SPRL)
EU/1/11/714/ - Zytiga (Janssen-Cilag International NV)
EU/1/11/713/ - Levetiracetam Actavis (Actavis Group PTC ehf.)
EU/1/11/712/ - Levetiracetam Accord (Accord Healthcare Limited)
EU/1/11/711/ - Matever (Pharmathen S.A.)
EU/1/11/710/ - Votubia (Novartis Europharm Limited)
EU/1/11/709/ - Buccolam (ViroPharma SPRL-BVBA)
EU/1/11/708/ - Entacapone Orion (Orion Corporation)
EU/1/11/707/ - Trajenta (Boehringer Ingelheim International GmbH)
EU/1/11/706/ - Levodopa/Carbidopa/Entacapone Orion (Orion Corporation)
EU/1/11/705/ - Vibativ (Astellas Pharma Europe B.V.)
EU/1/11/704/ - Victrelis (Merck Sharp & Dohme Limited)
EU/1/11/703/ - Xgeva (Amgen Europe B.V.)
EU/1/11/702/ - Levetiracetam ratiopharm (ratiopharm GmbH)
EU/1/11/701/ - Levetiracetam Teva (Teva Pharma B.V.)
EU/1/11/700/ - Benlysta (Glaxo Group Limited)
EU/1/11/699/ - Fampyra (Biogen Idec Limited)
EU/1/11/698/ - Yervoy (Bristol-Myers Squibb Pharma EEIG)
EU/1/11/697/ - Temozolomide Sun (Sun Pharmaceuticals Industries Europe B.V.)
EU/1/11/696/ - BYDUREON (Eli Lilly Nederland B.V.)
EU/1/11/695/ - Leganto (UCB Manufacturing Ireland Ltd.)
EU/1/11/694/ - NULOJIX (Bristol-Myers Squibb Pharma EEIG)
EU/1/11/693/ - Rivastigmine Actavis (Actavis Group PTC ehf.)
EU/1/11/692/ - Yellox (Croma-Pharma GmbH)
EU/1/11/691/ - Eliquis (Bristol-Myers Squibb/Pfizer EEIG)
EU/1/11/690/ - Zoely (Theramex S.r.l.)
EU/1/11/689/ - IOA (N.V. Organon)
EU/1/11/688/ - Cinryze (ViroPharma SPRL-BVBA)
EU/1/11/687/ - Hizentra (CSL Behring GmbH)
EU/1/11/686/ - Rasilamlo (Novartis Europharm Ltd)
EU/1/11/685/ - Ibandronic acid Sandoz (Sandoz Pharmaceuticals GmbH)
EU/1/11/683/ - Sprimeo HCT (Novartis Europharm Limited)
EU/1/11/682/ - Methylthioninium chloride Proveblue (Provepharm S.A.S.)
EU/1/11/681/ - Trobalt (Glaxo Group Limited)
EU/1/11/680/ - Riprazo HCT (Novartis Europharm Limited)
EU/1/11/679/ - Pravafenix (LABORATOIRES SMB SA)
EU/1/11/678/ - HALAVEN (Eisai Europe Limited)
EU/1/11/677/ - GILENYA (Novartis Europharm Ltd)
EU/1/11/676/ - JEVTANA (SANOFI)
EU/1/11/675/ - Leflunomide Teva (Teva Pharma B.V.)
EU/1/11/674/ - Repso (Teva Pharma B.V.)
EU/1/11/673/ - Ifirmacombi (KRKA, d. d., Novo mesto)
EU/1/11/672/ - Xeplion (Janssen-Cilag International NV)
EU/1/11/671/ - Xiapex (Pfizer Limited)
EU/1/11/669/ - Teysuno (Nordic Group BV)
EU/1/11/668/ - Daliresp (Nycomed GmbH)
EU/1/11/667/ - Esbriet (InterMune UK Ltd)
EU/1/11/666/ - Libertek (Nycomed GmbH)
EU/1/10/665/ - Entacapone Teva (Teva Pharma B.V.)
EU/1/10/664/ - Pumarix (GlaxoSmithKline Biologicals S.A.)
EU/1/10/663/ - Lamivudine / Zidovudine Teva (Teva Pharma B.V.)
EU/1/10/662/ - Docetaxel Teva Pharma (Teva Pharma B.V.)
EU/1/10/661/ - FLUENZ (MedImmune, LLC)
EU/1/10/660/ - Potactasol (Actavis Group PTC ehf.)
EU/1/10/659/ - Iasibon (Pharmathen S.A.)
EU/1/10/658/ - Aflunov (Novartis Vaccines and Diagnostics S.r.l.)
EU/1/10/657/ - Prepandemic Influenza (Novartis Vaccines and Diagnostics S.r.l.)
EU/1/10/656/ - Possia (AstraZeneca AB)
EU/1/10/655/ - Brilique (AstraZeneca AB)
EU/1/10/654/ - Leflunomide ratiopharm (ratiopharm GmbH)
EU/1/10/652/ - TOBI Podhaler (Novartis Europharm Limited)
EU/1/10/651/ - Clopidogrel HCS (HCS bvba)
EU/1/10/650/ - Clopidogrel Teva Generics B.V. (Teva Generics B.V.)
EU/1/10/649/ - Clopidogrel Teva Pharma B.V. (Teva Pharma B.V.)
EU/1/10/648/ - Twynsta (Boehringer Ingelheim International GmbH)
EU/1/10/647/ - Myclausen (Herbert J. Passauer GmbH & Co. KG)
EU/1/10/646/ - VPRIV (Shire Pharmaceuticals Ireland Limited)
EU/1/10/645/ - Brinavess (Merck Sharp & Dohme Limited)
EU/1/10/644/ - PecFent (Archimedes Development Ltd)
EU/1/10/643/ - Rapiscan (Rapidscan Pharma Solutions EU Ltd.)
EU/1/10/642/ - Ibandronic Acid Teva (Teva Pharma B.V.)
EU/1/10/641/ - Ruconest (Pharming Group N.V.)
EU/1/10/640/ - Sycrest (N.V. Organon)
EU/1/10/639/ - Telmisartan Actavis (Actavis Group PTC ehf. )
EU/1/10/638/ - Ozurdex (Allergan Pharmaceuticals (Ireland) Ltd,)
EU/1/10/637/ - Leflunomide medac (medac Gesellschaft für klinische Spezialpräparate mbH)
EU/1/10/636/ - Daxas (Nycomed GmbH)
EU/1/10/635/ - Olanzapine Apotex (Apotex Europe B.V.)
EU/1/10/634/ - Ribavirin Mylan (Generics [UK] Limited)
EU/1/10/633/ - Topotecan Hospira (Hospira UK Limited)
EU/1/10/632/ - Tolura (KRKA, d.d., Novo mesto)
EU/1/10/631/ - Nivestim (Hospira UK Limited)
EU/1/10/630/ - Docefrez (Sun Pharmaceuticals Industries Europe B.V.)
EU/1/10/628/ - Votrient (Glaxo Group Limited)
EU/1/10/627/ - Raloxifene Teva (Teva Pharma B.V.)
EU/1/10/626/ - Ribavirin BioPartners (BioPartners GmbH)
EU/1/10/625/ - Arzerra (Glaxo Group Ltd)
EU/1/10/623/ - DuoCover (Bristol-Myers Squibb Pharma EEIG)
EU/1/10/622/ - Tepadina (ADIENNE S.r.l.)
EU/1/10/621/ - Ristaben (Merck Sharp & Dohme Ltd.)
EU/1/10/620/ - Ristfor (Merck Sharp & Dohme Ltd.)
EU/1/10/619/ - DuoPlavin (Sanofi Pharma Bristol-Myers Squibb SNC)
EU/1/10/618/ - Prolia (Amgen Europe B.V.)
EU/1/10/617/ - Temozolomide Sandoz (Sandoz Pharmaceuticals GmbH)
EU/1/10/616/ - Temozolomide HEXAL (HEXAL AG)
EU/1/10/615/ - Temozolomide Hospira (Hospira UK Ltd.)
EU/1/10/614/ - Menveo (Novartis Vaccines and Diagnostics S.r.l.)
EU/1/10/612/ - Revolade (GlaxoSmithKline Trading Services Limited)
EU/1/09/611/ - Docetaxel Teva (Teva Pharma B.V.)
EU/1/09/610/ - Telmisartan Teva (Teva Pharma B.V.)
EU/1/09/609/ - Elonva (N.V. Organon)
EU/1/09/608/ - Urorec (Recordati Ireland Ltd.)
EU/1/09/607/ - Silodyx (Recordati Ireland Ltd.)
EU/1/09/606/ - Temozolomide Teva (Teva Pharma B.V.)
EU/1/09/605/ - Temomedac (medac Gesellschaft für klinische Spezialpräparate mbH)
EU/1/09/604/ - Leflunomide Winthrop (Sanofi-Aventis Deutschland GmbH)
EU/1/09/603/ - Sildenafil ratiopharm (ratiopharm GmbH)
EU/1/09/602/ - Scintimun (CIS bio international)
EU/1/09/601/ - Firdapse (BioMarin Europe Ltd)
EU/1/09/600/ - Zutectra (Biotest Pharma GmbH)
EU/1/09/599/ - Rivastigmine Sandoz (Sandoz Pharmaceuticals GmbH)
EU/1/09/598/ - Nevirapine Teva (Teva Pharma B.V.)
EU/1/09/597/ - Olazax (Glenmark Pharmaceuticals s.r.o.)
EU/1/09/596/ - Lamivudine Teva Pharma B.V. (Teva Pharma B.V.)
EU/1/09/595/ - Sildenafil Actavis (Actavis Group PTC ehf.)
EU/1/09/594/ - Hirobriz Breezhaler (Novartis Europharm Limited)
EU/1/09/593/ - Onbrez Breezhaler (Novartis Europharm Ltd)
EU/1/09/592/ - Olazax Disperzi (Glenmark Pharmaceuticals s.r.o.)
EU/1/09/591/ - Multaq (SANOFI)
EU/1/09/590/ - Prevenar 13 (Wyeth-Lederle Vaccines S.A.)
EU/1/09/589/ - Rivastigmine HEXAL (HEXAL AG)
EU/1/09/588/ - Olanzapine Glenmark Europe (Glenmark Generics (Europe) Limited)
EU/1/09/587/ - Olanzapine Glenmark (Glenmark Generics (Europe) Limited)
EU/1/09/586/ - Oslif Breezhaler (Novartis Europharm Limited)
EU/1/09/585/ - Rivastigmine 1 A Pharma (1 A Pharma GmbH)
EU/1/09/584/ - Sildenafil Teva (Teva Pharma B.V.)
EU/1/09/583/ - Irbesartan / Hydrochlorothiazide Teva (Teva Pharma B.V.)
EU/1/09/582/ - Rilonacept Regeneron (Regeneron UK Limited)
EU/1/09/581/ - Resolor (Shire-Movetis NV)
EU/1/09/580/ - Enyglid (KRKA, d. d., Novo mesto)
EU/1/09/579/ - Repaglinide Krka (KRKA, d. d., Novo mesto)
EU/1/09/578/ - Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals (GlaxoSmithKline Biologicals S.A.)
EU/1/09/577/ - Foclivia (Novartis Vaccines and Diagnostics S.r.l.)
EU/1/09/576/ - Irbesartan Teva (Teva Pharma B.V.)
EU/1/09/575/ - Copalia HCT (Novartis Europharm Ltd)
EU/1/09/574/ - Dafiro HCT (Novartis Europharm Ltd)
EU/1/09/573/ - Eporatio (ratiopharm GmbH)
EU/1/09/572/ - Vantavo (Merck Sharp & Dohme Ltd.)
EU/1/09/571/ - Pandemic influenza vaccine H5N1 BAXTER (Baxter AG)
EU/1/09/570/ - Imprida HCT (Novartis Europharm Ltd)
EU/1/09/569/ - Exforge HCT (Novartis Europharm Ltd)
EU/1/09/568/ - Clopidogrel Apotex (Apotex Europe B.V.)
EU/1/09/566/ - Lamivudine Teva (Teva Pharma B.V.)
EU/1/09/565/ - Biopoin (CT Arzneimittel GmbH)
EU/1/09/564/ - Ilaris (Novartis Europharm Limited)
EU/1/09/563/ - ChondroCelect (TiGenix NV)
EU/1/09/562/ - Clopidogrel Krka d.d. (KRKA, d.d., Novo mesto)
EU/1/09/561/ - Clopidogrel Teva Pharma (Teva Pharma B.V.)
EU/1/09/560/ - Clopidogrel DURA (Mylan dura GmbH)
EU/1/09/559/ - Clopidogrel Mylan (Mylan S.A.S)
EU/1/09/558/ - Zylagren (KRKA, d. d., Novo mesto)
EU/1/09/557/ - Clopidogrel Qualimed (Qualimed)
EU/1/09/556/ - Clopidogrel Krka (KRKA, d. d., Novo mesto)
EU/1/09/555/ - Clopidogrel TAD (TAD Pharma GmbH)
EU/1/09/554/ - Clopidogrel ratiopharm (Acino Pharma GmbH)
EU/1/09/553/ - Zyllt (KRKA, d.d., Novo mesto)
EU/1/09/552/ - Topotecan Teva (Teva Pharma B.V.)
EU/1/09/551/ - Vizarsin (KRKA, d.d., Novo mesto)
EU/1/09/550/ - Javlor (Pierre Fabre Médicament)
EU/1/09/546/ - Simponi (Janssen Biologics B.V.)
EU/1/09/545/ - Onglyza (Bristol Myers Squibb/AstraZeneca EEIG)
EU/1/09/544/ - Cimzia (UCB Pharma SA.)
EU/1/09/543/ - Cayston (Gilead Sciences International Limited)
EU/1/09/541/ - Clopidogrel ratiopharm GmbH (Acino Pharma GmbH)
EU/1/09/540/ - Clopidogrel Teva (Teva Pharma B.V.)
EU/1/09/539/ - Samsca (Otsuka Pharmaceutical Europe Ltd)
EU/1/09/538/ - Afinitor (Novartis Europharm Ltd)
EU/1/09/537/ - Mozobil (Genzyme Europe B.V.)
EU/1/09/536/ - Topotecan Actavis (Actavis Group PTC ehf.)
EU/1/09/535/ - Grepid (Pharmathen S.A.)
EU/1/09/533/ - Vedrop (Orphan Europe SARL)
EU/1/09/532/ - Clopidogrel Acino (Acino Pharma AG)
EU/1/09/531/ - Instanyl (Nycomed Danmark ApS)
EU/1/09/530/ - Repaglinide Teva (Teva Pharma B.V.)
EU/1/09/529/ - Victoza (Novo Nordisk A/S)
EU/1/09/528/ - Peyona (CHIESI FARMACEUTICI SpA)
EU/1/09/527/ - Ribavirin Teva Pharma BV (Teva Pharma B.V.)
EU/1/09/526/ - Iressa (AstraZeneca AB)
EU/1/09/525/ - Nimvastid (KRKA, d.d., Novo mesto)
EU/1/09/524/ - Qutenza (Astellas Pharma Europe B.V.)
EU/1/09/523/ - Modigraf (Astellas Pharma Europe B.V.)
EU/1/09/522/ - ellaOne (Laboratoire HRA Pharma)
EU/1/09/521/ - Renvela (Genzyme Europe B.V.)
EU/1/09/520/ - Exalief (BIAL - Portela & Ca, SA)
EU/1/09/519/ - Pantoloc Control (Nycomed GmbH)
EU/1/09/518/ - Pantecta Control (Nycomed GmbH)
EU/1/09/517/ - Pantozol Control (Nycomed GmbH)
EU/1/09/516/ - Somac Control (Nycomed GmbH)
EU/1/09/515/ - Controloc Control (Nycomed GmbH)
EU/1/09/514/ - Zebinix (BIAL - Portela & Ca, SA)
EU/1/09/513/ - Rivastigmine Teva (Teva Pharma B.V.)
EU/1/09/512/ - Removab (Fresenius Biotech GmbH)
EU/1/09/511/ - Conbriza (Pfizer Limited)
EU/1/09/510/ - Fertavid (Merck Sharp & Dohme Ltd.)
EU/1/09/509/ - Ribavirin Teva (Teva Pharma B.V.)
EU/1/09/508/ - Synflorix (GlaxoSmithKline Biologicals S.A.)
EU/1/08/507/ - IDflu (Sanofi Pasteur SA)
EU/1/08/506/ - Celvapan (Baxter AG)
EU/1/08/505/ - Intanza (Sanofi Pasteur MSD SNC)
EU/1/08/504/ - Firmagon (Ferring Pharmaceuticals A/S)
EU/1/08/503/ - Efient (Eli Lilly Nederland B.V.)
EU/1/08/502/ - Mepact (IDM PHARMA SAS)
EU/1/08/501/ - Ixiaro (Intercell AG)
EU/1/08/500/ - Fablyn (Dr. Friedrich Eberth Arzneimittel GmbH)
EU/1/08/499/ - Valdoxan (Les Laboratoires Servier)
EU/1/08/498/ - Thymanax (Servier (Ireland) Industries Limited)
EU/1/08/497/ - Nplate (Amgen Europe B.V.)
EU/1/08/496/ - Filgrastim Hexal (HEXAL AG)
EU/1/08/495/ - Zarzio (Sandoz GmbH)
EU/1/08/494/ - Stelara (Janssen-Cilag International NV)
EU/1/08/492/ - RoActemra (Roche Registration Limited)
EU/1/08/491/ - Rasilez HCT (Novartis Europharm Ltd)
EU/1/08/490/ - Pramipexole Teva (Teva Pharma B.V.)
EU/1/08/489/ - Opgenra (Olympus Biotech International Limited)
EU/1/08/488/ - Vidaza (Celgene Europe Ltd)
EU/1/08/486/ - Xiliarx (Novartis Europharm Ltd)
EU/1/08/485/ - Jalra (Novartis Europharm Ltd)
EU/1/08/484/ - Icandra (Novartis Europharm Ltd)
EU/1/08/483/ - Zomarist (Novartis Europharm Ltd)
EU/1/08/482/ - Azarga (Alcon Laboratories (UK) Ltd.)
EU/1/08/481/ - Kuvan (Merck Serono Europe Limited)
EU/1/08/480/ - Ifirmasta (KRKA, d.d., Novo mesto)
EU/1/08/479/ - Zypadhera (Eli Lilly Nederland B.V.)
EU/1/08/477/ - Ceplene (EpiCept GmbH)
EU/1/08/476/ - Adcirca (Eli Lilly Nederland B.V.)
EU/1/08/475/ - Olanzapine Mylan (Generics [UK] Limited)
EU/1/08/473/ - Evicel (Omrix Biopharmaceuticals N.V.)
EU/1/08/472/ - Xarelto (Bayer Pharma AG)
EU/1/08/470/ - Vimpat (UCB Pharma SA.)
EU/1/08/469/ - Oprymea (KRKA, d. d., Novo mesto)
EU/1/08/468/ - Intelence (Janssen-Cilag International NV)
EU/1/08/467/ - Doribax (Janssen-Cilag International NV)
EU/1/08/466/ - Bridion (N.V. Organon)
EU/1/08/465/ - Clopidogrel Zentiva (SANOFI)
EU/1/08/463/ - Relistor (TMC Pharma Services Ltd.)
EU/1/08/462/ - Ranexa (Menarini International Operations Luxembourg S.A.)
EU/1/08/461/ - Firazyr (Shire Orphan Therapies GmbH)
EU/1/08/460/ - Pelzont (Merck Sharp & Dohme Ltd)
EU/1/08/459/ - Tredaptive (Merck Sharp & Dohme Ltd)
EU/1/08/458/ - Trevaclyn (Merck Sharp & Dohme Ltd)
EU/1/08/457/ - Efficib (Merck Sharp & Dohme Ltd.)
EU/1/08/456/ - Velmetia (Merck Sharp & Dohme Ltd.)
EU/1/08/455/ - Janumet (Merck Sharp & Dohme Ltd.)
EU/1/08/454/ - Extavia (Novartis Europharm Ltd)
EU/1/08/453/ - Prepandrix (GlaxoSmithKline Biologicals S.A.)
EU/1/08/452/ - Pandemrix (GlaxoSmithKline Biologicals S.A.)
EU/1/08/451/ - Volibris (Glaxo Group Ltd)
EU/1/08/450/ - Biograstim (CT Arzneimittel GmbH)
EU/1/08/448/ - Mycamine (Astellas Pharma Europe B.V.)
EU/1/08/447/ - Adenuric (Menarini International Operations Luxembourg S.A.)
EU/1/08/446/ - Privigen (CSL Behring GmbH)
EU/1/08/445/ - Tevagrastim (Teva GmbH)
EU/1/08/444/ - Ratiograstim (ratiopharm GmbH)
EU/1/08/443/ - Thalidomide Celgene (Celgene Europe Limited)
EU/1/08/442/ - Pradaxa (Boehringer Ingelheim International GmbH)
EU/1/08/441/ - Effentora (Cephalon Europe)
EU/1/07/440/ - Tyverb (Glaxo Group Limited)
EU/1/07/439/ - Mycophenolate mofetil Teva (Teva Pharma B.V.)
EU/1/07/438/ - Myfenax (Teva Pharma B.V.)
EU/1/07/437/ - Ivemend (Merck Sharp & Dohme Limited)
EU/1/07/436/ - Isentress (Merck Sharp & Dohme Limited)
EU/1/07/435/ - Tesavel (Merck Sharp & Dohme Ltd)
EU/1/07/434/ - Avamys (Glaxo Group Ltd)
EU/1/07/433/ - Nevanac (Alcon Laboratories (UK) Ltd.)
EU/1/07/432/ - Silapo (STADA Arzneimittel AG)
EU/1/07/431/ - Retacrit (Hospira UK Limited)
EU/1/07/430/ - Atripla (Bristol-Myers Squibb and Gilead Sciences Limited)
EU/1/07/428/ - Abraxane (Celgene Europe Limited)
EU/1/07/427/ - Olanzapine Teva (Teva Pharma B.V.)
EU/1/07/426/ - Olanzapine Neopharma (Neopharma Limited)
EU/1/07/425/ - Eucreas (Novartis Europharm Ltd)
EU/1/07/424/ - Torisel (Pfizer Limited)
EU/1/07/423/ - Vectibix (Amgen Europe B.V.)
EU/1/07/422/ - Tasigna (Novartis Europharm Ltd)
EU/1/07/421/ - Glubrava (Takeda Global Research and Development Centre (Europe) Ltd)
EU/1/07/420/ - Cyanokit (Merck Santé s.a.s.)
EU/1/07/419/ - Cervarix (GlaxoSmithKline Biologicals S.A.)
EU/1/07/418/ - Celsentri (ViiV Healthcare UK Ltd)
EU/1/07/417/ - Yondelis (Pharma Mar, S.A.)
EU/1/07/416/ - Ecalta (Pfizer Limited)
EU/1/07/415/ - Zalasta (KRKA, d.d., Novo mesto)
EU/1/07/414/ - Galvus (Novartis Europharm Ltd)
EU/1/07/413/ - Gliolan (medac Gesellschaft für klinische Spezialpräparate mbH)
EU/1/07/412/ - Abseamed (Medice Arzneimittel Pütter GmbH & Co KG)
EU/1/07/411/ - Epoetin alfa Hexal (Hexal AG.)
EU/1/07/410/ - Binocrit (Sandoz GmbH)
EU/1/07/409/ - Riprazo (Novartis Europharm Ltd)
EU/1/07/407/ - Sprimeo (Novartis Europharm Ltd)
EU/1/07/405/ - Rasilez (Novartis Europharm Ltd)
EU/1/07/404/ - Flebogamma DIF (Instituto Grifols, S.A.)
EU/1/07/403/ - Atriance (Glaxo Group Limited)
EU/1/07/402/ - INCRELEX (Ipsen Pharma)
EU/1/07/401/ - alli (Glaxo Group Limited)
EU/1/07/400/ - Mircera (Roche Registration Limited)
EU/1/07/399/ - Aerinaze (Merck Sharp & Dohme Ltd)
EU/1/07/398/ - Optimark (Covidien Deutschland GmbH)
EU/1/07/397/ - Siklos (ADDMEDICA)
EU/1/07/396/ - Pergoveris (Merck Serono Europe Limited)
EU/1/07/395/ - Invega (Janssen-Cilag International NV)
EU/1/07/394/ - Optaflu (Novartis Vaccines and Diagnostics GmbH)
EU/1/07/393/ - Soliris (Alexion Europe S.A.S.)
EU/1/07/392/ - Circadin (RAD Neurim Pharmaceuticals EEC Limited)
EU/1/07/391/ - Revlimid (Celgene Europe Limited)
EU/1/07/390/ - Altargo (Glaxo Group Limited)
EU/1/07/389/ - Orencia (Bristol-Myers Squibb Pharma EEIG)
EU/1/07/388/ - Sebivo (Novartis Europharm Ltd)
EU/1/07/387/ - Advagraf (Astellas Pharma Europe B.V.)
EU/1/07/386/ - Toviaz (Pfizer Limited)
EU/1/07/385/ - Focetria (Novartis Vaccines and Diagnostics S.r.l.)
EU/1/07/384/ - Docetaxel Winthrop (Aventis Pharma S.A.)
EU/1/07/383/ - Januvia (Merck Sharp & Dohme Ltd)
EU/1/07/382/ - Xelevia (Merck Sharp & Dohme Ltd)
EU/1/06/381/ - Daronrix (GlaxoSmithKline Biologicals S.A.)
EU/1/06/380/ - PREZISTA (Janssen-Cilag International NV)
EU/1/06/379/ - Cystadane (Orphan Europe S.a.r.l.)
EU/1/06/378/ - Inovelon (Eisai Limited)
EU/1/06/377/ - Irbesartan HCT Zentiva (Ex-Winthrop) (Sanofi-aventis groupe)
EU/1/06/376/ - Irbesartan Zentiva (Sanofi-aventis groupe)
EU/1/06/374/ - Lucentis (Novartis Europharm Ltd)
EU/1/06/373/ - Imprida (Novartis Europharm Ltd)
EU/1/06/372/ - Copalia (Novartis Europharm Ltd)
EU/1/06/371/ - Dafiro (Novartis Europharm Ltd)
EU/1/06/370/ - Exforge (Novartis Europharm Ltd)
EU/1/06/368/ - Insulin Human Winthrop (Sanofi-Aventis Deutschland GmbH)
EU/1/06/367/ - Diacomit (Biocodex)
EU/1/06/366/ - Tandemact (Takeda Global Research and Development Centre (Europe) Ltd.)
EU/1/06/365/ - Elaprase (Shire Human Genetic Therapies AB)
EU/1/06/364/ - Adrovance (Merck Sharp & Dohme Ltd)
EU/1/06/363/ - Sprycel (Bristol-Myers Squibb Pharma EEIG)
EU/1/06/362/ - Byetta (Eli Lilly Nederland B.V.)
EU/1/06/361/ - Luminity (Lantheus MI UK Limited)
EU/1/06/360/ - Champix (Pfizer Ltd)
EU/1/06/359/ - Suboxone (RB Pharmaceuticals Limited)
EU/1/06/358/ - Silgard (Merck Sharp & Dohme Ltd)
EU/1/06/357/ - Gardasil (Sanofi Pasteur MSD, SNC)
EU/1/06/356/ - Exjade (Novartis Europharm Ltd)
EU/1/06/355/ - ATryn (GTC Biotherapeutics UK Limited)
EU/1/06/354/ - Competact (Takeda Global Research and Development Centre (Europe) Ltd)
EU/1/06/352/ - Intrinsa (Warner Chilcott UK Ltd)
EU/1/06/350/ - Savene (SpePharm Holding BV)
EU/1/06/348/ - RotaTeq (Sanofi Pasteur MSD, SNC)
EU/1/06/347/ - Sutent (Pfizer Ltd)
EU/1/06/346/ - Tysabri (Elan Pharma International Ltd.)
EU/1/06/343/ - Baraclude (Bristol-Myers Squibb Pharma EEIG)
EU/1/06/342/ - Nexavar (Bayer Pharma AG)
EU/1/06/341/ - Zostavax (Sanofi Pasteur MSD, SNC)
EU/1/06/340/ - Ganfort (Allergan Pharmaceuticals Ireland)
EU/1/06/339/ - Preotact (Nycomed Danmark ApS)
EU/1/06/338/ - DuoTrav (Alcon Laboratories (UK) Ltd.)
EU/1/06/337/ - M-M-RVAXPRO (Sanofi Pasteur MSD, SNC)
EU/1/06/336/ - Tygacil (Wyeth Europa Ltd.)
EU/1/06/335/ - Valtropin (BioPartners GmbH)
EU/1/06/334/ - Evoltra (Genzyme Europe BV)
EU/1/06/333/ - Myozyme (Genzyme Europe B.V.)
EU/1/06/332/ - Omnitrope (Sandoz GmbH)
EU/1/05/331/ - Neupro (Schwarz Pharma Ltd)
EU/1/05/330/ - Rotarix (GlaxoSmithKline Biologicals S.A.)
EU/1/05/329/ - Kiovig (Baxter AG)
EU/1/05/328/ - Cubicin (Novartis Europharm Ltd)
EU/1/05/325/ - Macugen (Pfizer Ltd)
EU/1/05/324/ - Naglazyme (BioMarin Europe Ltd)
EU/1/05/323/ - ProQuad (Sanofi Pasteur MSD, SNC)
EU/1/05/322/ - Yttriga (Eckert & Ziegler Radiopharma GmbH)
EU/1/05/320/ - Noxafil (Merck Sharp & Dohme Ltd.)
EU/1/05/319/ - Xolair (Novartis Europharm Ltd)
EU/1/05/318/ - Revatio (Pfizer Limited)
EU/1/05/317/ - Corlentor (Les Laboratoires Servier)
EU/1/05/316/ - Procoralan (Les Laboratoires Servier)
EU/1/05/315/ - APTIVUS (Boehringer Ingelheim International GmbH)
EU/1/05/314/ - Kepivance (Swedish Orphan Biovitrum AB (publ))
EU/1/05/312/ - Xyrem (UCB Pharma Ltd.)
EU/1/05/311/ - Tarceva (Roche Registration Limited)
EU/1/05/310/ - Fosavance (Merck Sharp & Dohme Ltd)
EU/1/05/308/ - Aclasta (Novartis Europharm Ltd)
EU/1/04/307/ - Zonegran (Eisai Limited)
EU/1/04/306/ - Aloxi (Helsinn Birex Pharmaceuticals Ltd)
EU/1/04/305/ - Truvada (Gilead Sciences International Limited)
EU/1/04/304/ - Azilect (Teva Pharma GmbH)
EU/1/04/303/ - Orfadin (Swedish Orphan Biovitrum International AB)
EU/1/04/302/ - Prialt (Eisai Limited)
EU/1/04/300/ - Avastin (Roche Registration Limited)
EU/1/04/299/ - Fendrix (GlaxoSmithKline Biologicals S.A.)
EU/1/04/298/ - Kivexa (ViiV Healthcare UK Ltd)
EU/1/04/297/ - Xeristar (Eli Lilly Nederland B.V.)
EU/1/04/296/ - Cymbalta (Eli Lilly Nederland B.V.)
EU/1/04/295/ - Xagrid (Shire Pharmaceutical Contracts Ltd)
EU/1/04/294/ - Emselex (Novartis Europharm Ltd)
EU/1/04/292/ - Mimpara (Amgen Europe B.V.)
EU/1/04/290/ - Alimta (Eli Lilly Nederland B.V.)
EU/1/04/289/ - Angiox (The Medicines Company UK Ltd)
EU/1/04/288/ - Protelos (Les Laboratoires Servier)
EU/1/04/287/ - Osseor (Les Laboratoires Servier)
EU/1/04/286/ - Wilzin (Orphan Europe S.a.r.l.)
EU/1/04/285/ - Apidra (Sanofi-Aventis Deutschland GmbH)
EU/1/04/284/ - Pedea (Orphan Europe SARL)
EU/1/04/283/ - Ariclaim (Eli Lilly Nederland B.V.)
EU/1/04/282/ - Telzir (ViiV Healthcare UK Ltd)
EU/1/04/281/ - Erbitux (Merck KGaA)
EU/1/04/280/ - Yentreve (Eli Lilly Nederland B.V.)
EU/1/04/279/ - Lyrica (Pfizer Ltd)
EU/1/04/278/ - Levemir (Novo Nordisk A/S)
EU/1/04/277/ - TachoSil (Nycomed Austria GmbH)
EU/1/04/276/ - Abilify (Otsuka Pharmaceutical Europe Ltd)
EU/1/04/275/ - Litak (Lipomed GmbH)
EU/1/04/274/ - VELCADE (Janssen-Cilag International NV)
EU/1/04/273/ - Lysodren (Laboratoire HRA Pharma)
EU/1/03/271/ - Advate (Baxter AG)
EU/1/03/270/ - Kentera (Nicobrand Limited )
EU/1/03/269/ - Faslodex (AstraZeneca UK Limited)
EU/1/03/268/ - Cholestagel (Genzyme Europe B.V.)
EU/1/03/267/ - Reyataz (Bristol-Myers Squibb Pharma EEIG)
EU/1/03/266/ - Bondenza (Roche Registration Limited)
EU/1/03/265/ - Bonviva (Roche Registration Limited)
EU/1/03/264/ - Zevalin (Bayer Pharma AG)
EU/1/03/263/ - Dukoral (Crucell Sweden AB)
EU/1/03/262/ - Emend (Merck Sharp & Dohme Ltd)
EU/1/03/261/ - Emtriva (Gilead Sciences International Limited)
EU/1/03/260/ - Stalevo (Orion Corporation)
EU/1/03/256/ - Humira (Abbott Laboratories Ltd)
EU/1/03/255/ - Ventavis (Bayer Pharma AG)
EU/1/03/254/ - Busilvex (Pierre Fabre Médicament)
EU/1/03/253/ - Aldurazyme (Genzyme Europe B.V.)
EU/1/03/252/ - Fuzeon (Roche Registration Limited)
EU/1/03/251/ - Hepsera (Gilead Sciences International Limited)
EU/1/03/250/ - Ytracis (CIS bio international)
EU/1/03/249/ - Vivanza (Bayer Pharma AG)
EU/1/03/248/ - Levitra (Bayer Pharma AG)
EU/1/03/247/ - Forsteo (Eli Lilly Nederland B.V.)
EU/1/02/246/ - Carbaglu (Orphan Europe)
EU/1/02/240/ - Somavert (Pfizer Ltd)
EU/1/02/238/ - Zavesca (Actelion Registration Ltd)
EU/1/02/237/ - Cialis (Eli Lilly Nederland B.V.)
EU/1/02/234/ - Protaphane (Novo Nordisk A/S)
EU/1/02/233/ - Insulatard (Novo Nordisk A/S)
EU/1/02/231/ - Mixtard (Novo Nordisk A/S)
EU/1/02/230/ - Actrapid (Novo Nordisk A/S)
EU/1/02/229/ - Actraphane (Novo Nordisk A/S)
EU/1/02/227/ - Neulasta (Amgen Europe B.V.)
EU/1/02/226/ - InductOs (Medtronic Biopharma BV)
EU/1/02/224/ - Ambirix (GlaxoSmithKline Biologicals S.A.)
EU/1/02/223/ - Evra (Janssen-Cilag International NV)
EU/1/02/222/ - Tamiflu (Roche Registration Limited)
EU/1/02/221/ - Pegasys (Roche Registration Limited)
EU/1/02/220/ - Tracleer (Actelion Registration Ltd)
EU/1/02/219/ - Ebixa (H. Lundbeck A/S)
EU/1/02/218/ - Axura (Merz Pharmaceuticals GmbH)
EU/1/02/217/ - Opatanol (Alcon Laboratories (UK) Ltd.)
EU/1/02/216/ - Invanz (Merck Sharp & Dohme Ltd)
EU/1/02/215/ - PritorPlus (Bayer Pharma AG)
EU/1/02/214/ - Kinzalkomb (Bayer Pharma AG)
EU/1/02/213/ - MicardisPlus (Boehringer Ingelheim International GmbH)
EU/1/02/212/ - Vfend (Pfizer Ltd)
EU/1/02/209/ - Dynastat (Pfizer Ltd)
EU/1/02/206/ - Arixtra (Glaxo Group Ltd.)
EU/1/02/205/ - Lumigan (Allergan Pharmaceuticals Ireland)
EU/1/02/204/ - Trisenox (Cephalon Europe)
EU/1/02/203/ - Kineret (Swedish Orphan Biovitrum AB (publ))
EU/1/02/201/ - Protopic (Astellas Pharma Europe B.V.)
EU/1/01/200/ - Viread (Gilead Sciences International Limited)
EU/1/01/199/ - Travatan (Alcon Laboratories (UK) Ltd.)
EU/1/01/198/ - Glivec (Novartis Europharm Ltd)
EU/1/01/197/ - Foscan (Biolitec pharma Ltd)
EU/1/01/196/ - CANCIDAS (Merck Sharp & Dohme Ltd)
EU/1/01/195/ - Liprolog (Eli Lilly Nederland B.V.)
EU/1/01/194/ - INOmax (INO Therapeutics AB)
EU/1/01/193/ - MabCampath (Genzyme Europe B.V.)
EU/1/01/191/ - Ketek (Aventis Pharma S.A.)
EU/1/01/190/ - Ceprotin (Baxter AG)
EU/1/01/189/ - Replagal (Shire Human Genetic Therapies AB)
EU/1/01/188/ - Fabrazyme (Genzyme Europe B.V.)
EU/1/01/187/ - DepoCyte (Pacira Limited)
EU/1/01/186/ - Nonafact (Sanquin)
EU/1/01/185/ - Aranesp (Amgen Europe B.V.)
EU/1/01/183/ - HBVAXPRO (Sanofi Pasteur MSD, SNC)
EU/1/01/179/ - Osigraft (Olympus Biotech International Limited)
EU/1/01/178/ - Targretin (Eisai Limited)
EU/1/01/177/ - SonoVue (Bracco International B.V.)
EU/1/01/176/ - Zometa (Novartis Europharm Ltd)
EU/1/01/174/ - Starlix (Novartis Europharm Ltd)
EU/1/01/173/ - Vaniqa (Almirall, S.A.)
EU/1/01/172/ - Kaletra (Abbott Laboratories)
EU/1/01/171/ - Rapamune (Pfizer Limited)
EU/1/00/170/ - Fasturtec (SANOFI)
EU/1/00/169/ - Metalyse (Boehringer Ingelheim International GmbH)
EU/1/00/167/ - Prevenar (Wyeth-Lederle Vaccines S.A.)
EU/1/00/166/ - NeuroBloc (Eisai Limited)
EU/1/00/165/ - Ovitrelle (Merck Serono Europe Limited)
EU/1/00/164/ - NutropinAq (Ipsen Pharma)
EU/1/00/163/ - Xeloda (Roche Registration Limited)
EU/1/00/162/ - Prandin (Novo Nordisk A/S)
EU/1/00/161/ - Neoclarityn (Merck Sharp & Dohme Ltd.)
EU/1/00/160/ - Aerius (Merck Sharp & Dohme Ltd.)
EU/1/00/157/ - Azomyr (Merck Sharp & Dohme Limited)
EU/1/00/156/ - Trizivir (ViiV Healthcare UK Limited)
EU/1/00/155/ - Luveris (Merck Serono Europe Limited)
EU/1/00/153/ - Infanrix penta (GlaxoSmithKline Biologicals S.A.)
EU/1/00/152/ - Infanrix hexa (GlaxoSmithKline Biologicals S.A.)
EU/1/00/151/ - Glustin (Takeda Global Research and Development Centre (Europe) Ltd)
EU/1/00/150/ - Actos (Takeda Global Research and Development Centre (Europe) Ltd)
EU/1/00/149/ - Panretin (Eisai Limited)
EU/1/00/146/ - Keppra (UCB Pharma SA.)
EU/1/00/145/ - Herceptin (Roche Registration Limited)
EU/1/00/144/ - Helixate NexGen (Bayer Schering Pharma AG)
EU/1/00/143/ - Kogenate Bayer (Bayer Pharma AG)
EU/1/00/142/ - NovoMix (Novo Nordisk A/S)
EU/1/00/141/ - Myocet (Cephalon Europe)
EU/1/00/140/ - Visudyne (Novartis Europharm Ltd)
EU/1/00/135/ - DaTSCAN (GE Healthcare Limited)
EU/1/00/134/ - Lantus (Sanofi-Aventis Deutschland GmbH)
EU/1/00/133/ - Optisulin (Sanofi-Aventis Deutschland GmbH)
EU/1/00/132/ - ViraferonPeg (Merck Sharp & Dohme Limited)
EU/1/00/131/ - PegIntron (Merck Sharp & Dohme Limited)
EU/1/00/130/ - Orgalutran (N.V. Organon)
EU/1/00/129/ - Azopt (Alcon Laboratories (UK) Ltd.)
EU/1/99/127/ - IntronA (Merck Sharp & Dohme Ltd.)
EU/1/99/126/ - Enbrel (Pfizer Limited)
EU/1/99/125/ - Zyprexa Velotab (Eli Lilly Nederland B.V.)
EU/1/99/124/ - Tractocile (Ferring Pharmaceuticals A/S)
EU/1/99/123/ - Renagel (Genzyme Europe B.V.)
EU/1/99/122/ - Thyrogen (Genzyme Europe B.V.)
EU/1/99/120/ - Ammonaps (Swedish Orphan Biovitrum International AB)
EU/1/99/119/ - NovoRapid (Novo Nordisk A/S)
EU/1/99/118/ - Arava (Sanofi-Aventis Deutschland GmbH)
EU/1/99/117/ - Synagis (Abbott Laboratories Ltd)
EU/1/99/116/ - Remicade (Janssen Biologics B.V.)
EU/1/99/114/ - Zeffix (Glaxo Group Ltd.)
EU/1/99/112/ - Ziagen (ViiV Healthcare UK Ltd)
EU/1/99/111/ - Stocrin (Merck Sharp & Dohme Ltd)
EU/1/99/110/ - Sustiva (Bristol-Myers Squibb Pharma EEIG)
EU/1/99/109/ - Integrilin (Glaxo Group Ltd)
EU/1/99/108/ - Ferriprox (Apotex Europe B.V.)
EU/1/99/107/ - Rebetol (Schering Plough Europe)
EU/1/99/103/ - ReFacto AF (Pfizer Limited)
EU/1/99/102/ - Sonata (Meda AB)
EU/1/99/101/ - Regranex (Janssen-Cilag International NV)
EU/1/99/100/ - Cetrotide (SERONO EUROPE LIMITED)
EU/1/99/099/ - Zerene (Meda AB)
EU/1/99/097/ - Beromun (Boehringer Ingelheim International GmbH)
EU/1/98/096/ - Temodal (Merck Sharp & Dohme Limited)
EU/1/98/095/ - Emadine (Alcon Laboratories (UK) Ltd.)
EU/1/98/092/ - Prometax (Novartis Europharm Ltd)
EU/1/98/091/ - Kinzalmono (Bayer Pharma AG)
EU/1/98/090/ - Micardis (Boehringer Ingelheim International GmbH)
EU/1/98/089/ - Pritor (Bayer Pharma AG)
EU/1/98/086/ - CoAprovel (Sanofi Pharma Bristol-Myers Squibb SNC)
EU/1/98/085/ - Karvezide (Bristol-Myers Squibb Pharma EEIG)
EU/1/98/084/ - Simulect (Novartis Europharm Ltd)
EU/1/98/082/ - Comtess (Orion Corporation)
EU/1/98/081/ - Comtan (Novartis Europharm Ltd)
EU/1/98/080/ - Aldara (Meda AB)
EU/1/98/077/ - Viagra (Pfizer Limited)
EU/1/98/076/ - NovoNorm (Novo Nordisk A/S)
EU/1/98/074/ - Optruma (Eli Lilly Nederland B.V.)
EU/1/98/073/ - Evista (DAIICHI SANKYO EUROPE GmbH)
EU/1/98/071/ - Xenical (Roche Registration Limited)
EU/1/98/070/ - Iscover (Bristol-Myers Squibb Pharma EEIG)
EU/1/98/069/ - Plavix (Sanofi Pharma Bristol-Myers Squibb SNC)
EU/1/98/067/ - Mabthera (Roche Registration Limited)
EU/1/98/066/ - Exelon (Novartis Europharm Ltd)
EU/1/98/065/ - Optison (GE Healthcare AS)
EU/1/98/064/ - Pylobactell (Torbet Laboratories Limited)
EU/1/98/063/ - Rebif (Merck Serono Europe Limited)
EU/1/98/058/ - Combivir (ViiV Healthcare UK Ltd)
EU/1/97/057/ - Quadramet (CIS bio international)
EU/1/97/055/ - Viramune (Boehringer Ingelheim International GmbH)
EU/1/97/054/ - Viracept (Roche Registration Limited)
EU/1/97/053/ - Cerezyme (Genzyme Europe B.V.)
EU/1/97/051/ - Mirapexin (Boehringer Ingelheim International GmbH)
EU/1/97/050/ - Sifrol (Boehringer Ingelheim International GmbH)
EU/1/97/049/ - Karvea (Bristol-Myers Squibb Pharma EEIG)
EU/1/97/047/ - BeneFIX (Pfizer Limited)
EU/1/97/046/ - Aprovel (Sanofi Pharma Bristol-Myers Squibb SNC)
EU/1/97/045/ - Helicobacter test INFAI (INFAI, Institut für biomedizinische Analytik & NMR Imaging GmbH)
EU/1/97/044/ - Tasmar (Meda AB)
EU/1/97/043/ - Revasc (Canyon Pharmaceuticals Ltd)
EU/1/97/040/ - Teslascan (GE Healthcare AS)
EU/1/97/039/ - Cystagon (Orphan Europe S.a.r.l.)
EU/1/97/037/ - Vistide (Gilead Sciences International Limited)
EU/1/97/033/ - Avonex (Biogen Idec Ltd)
EU/1/97/032/ - LeukoScan (Immunomedics GmbH)
EU/1/97/031/ - NeoRecormon (Roche Registration Limited)
EU/1/97/030/ - Insuman (Sanofi-Aventis Deutschland GmbH)
EU/1/97/029/ - Twinrix Paediatric (GlaxoSmithKline Biologicals S.A.)
EU/1/96/027/ - Hycamtin (SmithKline Beecham Ltd.)
EU/1/96/026/ - Invirase (Roche Registration Limited)
EU/1/96/024/ - Crixivan (Merck Sharp & Dohme Ltd)
EU/1/96/022/ - Zyprexa (Eli Lilly Nederland B.V.)
EU/1/96/020/ - Twinrix Adult (GlaxoSmithKline Biologicals S.A.)
EU/1/96/018/ - Rapilysin (Actavis Group PTC ehf.)
EU/1/96/016/ - Norvir (Abbott Laboratories Ltd)
EU/1/96/015/ - Epivir (ViiV Healthcare UK Ltd)
EU/1/96/014/ - Tritanrix HepB (GlaxoSmithKline Biologicals S.A.)
EU/1/96/012/ - Bondronat (Roche Registration Limited)
EU/1/96/011/ - Caelyx (Janssen-Cilag International NV)
EU/1/96/010/ - Rilutek (Aventis Pharma S.A.)
EU/1/96/009/ - Zerit (Bristol-Myers Squibb Pharma EEIG)
EU/1/96/008/ - Puregon (Organon N.V.)
EU/1/96/007/ - Humalog (Eli Lilly Nederland B.V.)
EU/1/96/006/ - NovoSeven (Novo Nordisk A/S)
EU/1/96/005/ - CellCept (Roche Registration Limited)
EU/1/96/004/ - Fareston (Orion Corporation)
EU/1/95/003/ - Betaferon (Bayer Pharma AG)
EU/1/95/002/ - Taxotere (Aventis Pharma S.A.)
EU/1/95/001/ - GONAL-f (Merck Serono Europe Ltd.)
Printable version
Last update:23/05/2012
|
Top
